Covid19
Intranasal COVID-19 vaccine candidate generates robust immune response – Healio

BOSTON — Two doses of an experimental live-attenuated intranasal COVID-19 vaccine generated a robust immune response, according to phase one data …
BOSTON — Two doses of an experimental live-attenuated intranasal COVID-19 vaccine generated a robust immune response, according to phase one data …